On 17 June 2022, All.Can published its Efficiency Metrics study, a policy research which proposes a set of internationally applicable and real-world measures generated and collected from daily clinical practice. The report can be used by relevant stakeholders to assess efficiency in cancer care and aims to harmonise and set standards in cancer care efficiency globally.

The study was produced by The Health Value Alliance in partnership with the University of Southampton.

Launched at All.Can’s Global Summit which took place on 15 & 16 June 2022, the findings of this report were received with great attention by panellists and attendees as an important step toward the harmonization and standardization of cancer care metrics globally.

The research combined the findings from 83 academic articles, 43 grey literature publications, 15 cancer registry websites, 1 international registry and 20 interviews with different stakeholders from across the cancer care ecosystem and identified 8 core metric categories:

  • Time to diagnosis
  • Percentage of cancers diagnosed through emergency presentation
  • Primary care interval
  • Time from tissue diagnosis to treatment
  • Percentage of patients documented as having seen a Clinical Nurse Specialist (CNS)
  • Percentage of patients who received chemotherapy in the last 14 days of life
  • Patient experience
  • Patient involvement in decision-making